Product
Intravenous Placebo
6 clinical trials
16 indications
Indication
Atopic DermatitisIndication
CandidemiaIndication
MycosisIndication
Fungal InfectionIndication
invasive candidiasisIndication
PainIndication
PostoperativeIndication
StrokeIndication
DeliriumIndication
Fungal sepsisIndication
Invasive CandidiasisIndication
PneumocystisIndication
Mold InfectionIndication
Invasive Fungal DiseaseIndication
AspergillosisClinical trial
A Phase I/IIA, Randomized, Placebo-Controlled, Single-Ascending Dose (Part A, Participant- and Investigator-Blind) and Repeated-Dose (Part B, Participant-, Investigator-, and Sponsor-Blind) Study to Investigate the Safety, Pharmacokinetics, and Efficacy of UCB9741 in Healthy Study Participants (Part A) and in Study Participants With Moderate-to-Severe Atopic Dermatitis (Part B)Status: Active (not recruiting), Estimated PCD: 2024-04-23
Clinical trial
A Phase 3, Multicenter, Randomized, Double-blind Study of the Efficacy and Safety of Rezafungin for Injection vs. Intravenous Caspofungin Followed by Oral Fluconazole Step Down in the Treatment of Subjects With Candidemia and/or Invasive CandidiasisStatus: Completed, Estimated PCD: 2021-10-07
Clinical trial
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter, Evaluation of the Safety of N1539 Following Major SurgeryStatus: Completed, Estimated PCD: 2017-03-01
Clinical trial
A Randomized, Double Blind, Multicenter, Multinational, Placebo Controlled, Parallel Group, Single Dose, Adaptive Efficacy and Safety Study of Glenzocimab Used as an add-on Therapy on Top of Standard of Care un the 4.5 Hours Following an Acute Ischemic StrokeStatus: Active (not recruiting), Estimated PCD: 2024-01-31
Clinical trial
Minimizing ICU Neurological Dysfunction With Dexmedetomidine-induced Sleep (MINDDS II)Status: Not yet recruiting, Estimated PCD: 2027-10-31
Clinical trial
A Phase 3, Multicenter, Randomized, Double-Blind Study of the Efficacy and Safety of Rezafungin for Injection Versus the Standard Antimicrobial Regimen to Prevent Invasive Fungal Diseases in Adults Undergoing Allogeneic Blood and Marrow Transplantation (The ReSPECT Study)Status: Recruiting, Estimated PCD: 2024-08-01